Mediolanum International Funds Limited (MIFL) is a management company approved by the Central Bank of Ireland to manage UCITS & Non UCITS Funds as well as the Research & Development (R&D) and funds product innovation centre (MedLab®) for the Mediolanum Banking Group.

MIFL undertakes significant proprietary R&D and collaborates with selected international partners, leveraging on its open innovation platform and proprietary process (MedInSynC®), with a view towards developing in house solutions tailored to meet clients’ needs. We believe this ensures that we can deliver value adding investment products and services to our predominantly European retail client base. MIFL is also one of the pioneers for the protection of Intellectual Property in the funds industry and is very active in shaping evolving market best practice in this area.